Clinical Trials in Salt Lake City

Showing 13801-13820 of 14,325 trials

A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved Dose

NCT00202982

This is a study to test if a new higher dose of Copaxone is more effective in treating relapsing-remitting multiple sclerosis than the currently available 20 mg dose.

Relapse-Remitting Multiple Sclerosis

Teva Branded Pharmaceutical Products R&D, Inc.90 participantsStarted Aug 2003

La Jolla, California, United States • Oceanside, California, United States • Atlanta, Georgia, United States +17 more locations

COMPLETEDPhase 421 miles

Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular Safety

NCT00359801

The purpose of this study is to evaluate the long-term pulmonary and cardiovascular safety of Exubera in routine clinical practice.

Diabetes Mellitus

Pfizer1,976 participantsStarted Jul 2006

Bay Minette, Alabama, United States • Fairhope, Alabama, United States • Graysville, Alabama, United States +194 more locations

A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved Dose

Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular Safety

Find Trials by Condition in Salt Lake City

Identifying the Anti-Blood-Clotting Compounds in Garlic

A Phase III Trial For Patients With Metastatic Breast Cancer

Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation

A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD

Memory Impairment Study (Mild Cognitive Impairment Study)

Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks*

Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome

Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis

Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke

PLASMA Trial: A Dose-Response Study of A-002 In Subjects With Stable Coronary Artery Disease

Paclitaxel With or Without PSC 833 in Treating Patients With Metastatic Breast Cancer

Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLC

SU011248 In The Treatment Of Patients With Bevacizumab (Avastin)-Refractory Metastatic Renal Cell Carcinoma

Study to Determine if Avonex and Rebif Work Comparably Well in Subjects With Relapsing Multiple Sclerosis

Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity

Quality of Life in Pediatric Inflammatory Bowel Disease

Safety and Efficacy Evaluation of Erbium Treatment

North American Study for the Treatment of Refractory Ascites (NASTRA)